Tag: biopharma growth

…
Altcoins

Morgan Stanley just upgraded Johnson & Johnson to Overweight, raising the price target to $262 on the back of an...
28/01/2026
1 views
Read More
…
Altcoins

A leading analyst just initiated coverage on Insmed with a Buy rating and a price target suggesting over 30% upside....
23/01/2026
1 views
Read More
?>